Recurrent renal stone disease—advances in pathogenesis and clinical management
- 1 August 2001
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 358 (9282) , 651-656
- https://doi.org/10.1016/s0140-6736(01)05782-8
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Should Dietary Calcium and Protein Be Restricted in Patients with Nephrolithiasis?Nutrition Reviews, 2009
- Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasisKidney International, 2000
- SELECTIVE CYCLOOXYGENASE-2 INHIBITORS REDUCE URETERAL CONTRACTION IN VITRO: A BETTER ALTERNATIVE FOR RENAL COLIC?Journal of Urology, 2000
- Treatment of cystinuriaPediatric Nephrology, 1999
- Lithogenic risk factors in normal black volunteers, and black and white recurrent stone formersBJU International, 1999
- Indapamide (Natrilix): the agent of choice in the treatment of recurrent renal calculi associated with idiopathic hypercalciuriaBritish Journal of Urology, 1996
- Further evidence linking urolithiasis and blood coagulation: Urinary prothrombin fragment 1 is present in stone matrixKidney International, 1996
- Crystallization Properties in Urine from Calcium Oxalate Stone FormersJournal of Urology, 1995
- Molecular Characteristics of Uronic-Acid-Rich Protein, a Strong Inhibitor of Calcium Oxalate Crystallization In VitroBiochemical and Biophysical Research Communications, 1993
- Renal handling of citrateKidney International, 1990